LIPOCINE INC. Investment Income, Interest
LIPOCINE INC. (LPCN) reported Investment Income, Interest of $219.85 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-04
- LIPOCINE INC. investment income, interest for the quarter ending 2026-06-30 was $219.85K, a 10.68% increase year-over-year.
- LIPOCINE INC. investment income, interest for the quarter ending 2026-03-31 was $177.57K, a 21.26% decline year-over-year.
- LIPOCINE INC. investment income, interest for the quarter ending 2025-12-31 was $145.72K, a 37.49% decline year-over-year.
- LIPOCINE INC. investment income, interest for the quarter ending 2025-09-30 was $174.21K, a 36.32% decline year-over-year.
- LIPOCINE INC. investment income, interest for fiscal 2025 was $744.07K, a 35.12% decline from fiscal 2024.
- LIPOCINE INC. investment income, interest for fiscal 2024 was $1.15M, a 16.10% decline from fiscal 2023.
- LIPOCINE INC. investment income, interest for fiscal 2023 was $1.37M, a 138.73% increase from fiscal 2022.
- LIPOCINE INC. investment income, interest for fiscal 2022 was $572.58K, a 745.76% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $219.85K 10-Q · filed 2026-08-04 | $397.42K 10-Q · filed 2026-08-04 | $543.14K derived: sum of 3 quarters · filed 2026-08-04 | $717.35K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $177.57K 10-Q · filed 2026-05-07 | $323.29K derived: sum of 2 quarters · filed 2026-05-07 | $497.50K derived: sum of 3 quarters · filed 2026-05-07 | $696.13K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $145.72K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $319.93K derived: sum of 2 quarters · filed 2026-03-10 | $518.56K derived: sum of 3 quarters · filed 2026-08-04 | $744.07K 10-K · filed 2026-03-10 |
| 2025-09-30 | $174.21K 10-Q · filed 2025-11-06 | $372.85K derived: sum of 2 quarters · filed 2026-08-04 | $598.36K 10-Q · filed 2025-11-06 | $831.47K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $198.64K 10-Q · filed 2026-08-04 | $424.15K 10-Q · filed 2026-08-04 | $657.27K derived: sum of 3 quarters · filed 2026-08-04 | $930.84K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $225.51K 10-Q · filed 2026-05-07 | $458.63K derived: sum of 2 quarters · filed 2026-05-07 | $732.20K derived: sum of 3 quarters · filed 2026-05-07 | $1.04M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $233.12K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $506.69K derived: sum of 2 quarters · filed 2026-03-10 | $815.54K derived: sum of 3 quarters · filed 2026-03-10 | $1.15M 10-K · filed 2026-03-10 |
| 2024-09-30 | $273.57K 10-Q · filed 2025-11-06 | $582.42K derived: sum of 2 quarters · filed 2025-11-06 | $913.78K 10-Q · filed 2025-11-06 | $1.21M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $308.85K 10-Q · filed 2025-08-05 | $640.21K 10-Q · filed 2025-08-05 | $939.59K derived: sum of 3 quarters · filed 2025-08-05 | $1.26M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $331.36K 10-Q · filed 2025-05-08 | $630.74K derived: sum of 2 quarters · filed 2025-05-08 | $948.31K derived: sum of 3 quarters · filed 2025-05-08 | $1.33M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $299.38K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $616.95K derived: sum of 2 quarters · filed 2025-03-13 | $996.47K derived: sum of 3 quarters · filed 2025-03-13 | $1.37M 10-K · filed 2025-03-13 |
| 2023-09-30 | $317.57K 10-Q · filed 2024-11-07 | $697.09K derived: sum of 2 quarters · filed 2024-11-07 | $1.07M 10-Q · filed 2024-11-07 | $1.36M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $379.52K 10-Q · filed 2024-08-08 | $749.99K 10-Q · filed 2024-08-08 | $1.05M derived: sum of 3 quarters · filed 2024-08-08 | $1.21M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $370.47K 10-Q · filed 2024-05-09 | $667.63K derived: sum of 2 quarters · filed 2024-05-09 | $831.59K derived: sum of 3 quarters · filed 2024-05-09 | $901.47K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $297.16K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $461.12K derived: sum of 2 quarters · filed 2024-03-07 | $531.00K derived: sum of 3 quarters · filed 2024-03-07 | $572.58K 10-K · filed 2024-03-07 |
| 2022-09-30 | $163.97K 10-Q · filed 2023-11-08 | $233.84K derived: sum of 2 quarters · filed 2023-11-08 | $275.42K 10-Q · filed 2023-11-08 | $297.86K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $69.88K 10-Q · filed 2023-08-10 | $111.45K 10-Q · filed 2023-08-10 | $133.90K derived: sum of 3 quarters · filed 2023-08-10 | $151.16K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $41.58K 10-Q · filed 2023-05-11 | $64.02K derived: sum of 2 quarters · filed 2023-05-11 | $81.28K derived: sum of 3 quarters · filed 2023-05-11 | $98.63K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $22.44K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $39.71K derived: sum of 2 quarters · filed 2023-03-10 | $57.05K derived: sum of 3 quarters · filed 2023-03-10 | $67.70K 10-K · filed 2023-03-10 |
| 2021-09-30 | $17.26K 10-Q · filed 2022-11-09 | $34.61K derived: sum of 2 quarters · filed 2022-11-09 | $45.26K 10-Q · filed 2022-11-09 | $48.18K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $17.34K 10-Q · filed 2022-08-08 | $27.99K 10-Q · filed 2022-08-08 | $30.91K derived: sum of 3 quarters · filed 2022-08-08 | $36.53K derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $10.65K 10-Q · filed 2022-05-09 | $13.57K derived: sum of 2 quarters · filed 2022-05-09 | $19.18K derived: sum of 3 quarters · filed 2022-05-09 | $26.36K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $2.92K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $8.54K derived: sum of 2 quarters · filed 2022-03-09 | $15.71K derived: sum of 3 quarters · filed 2022-03-09 | $75.65K 10-K · filed 2022-03-09 |
| 2020-09-30 | $5.61K 10-Q · filed 2021-11-10 | $12.79K derived: sum of 2 quarters · filed 2021-11-10 | $72.73K 10-Q · filed 2021-11-10 | $147.39K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $7.18K 10-Q · filed 2021-08-05 | $67.11K 10-Q · filed 2021-08-05 | $141.77K derived: sum of 3 quarters · filed 2021-08-05 | $240.76K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $59.94K 10-Q · filed 2021-05-06 | $134.60K derived: sum of 2 quarters · filed 2021-05-06 | $233.58K derived: sum of 3 quarters · filed 2021-05-06 | $358.17K derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $74.66K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $173.65K derived: sum of 2 quarters · filed 2021-03-11 | $298.23K derived: sum of 3 quarters · filed 2021-03-11 | $423.49K 10-K · filed 2021-03-11 |
| 2019-09-30 | $98.99K 10-Q · filed 2020-11-10 | $223.57K derived: sum of 2 quarters · filed 2020-11-10 | $348.83K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $124.58K 10-Q · filed 2020-08-06 | $249.85K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $125.27K 10-Q · filed 2020-05-07 | |||
| 2018-09-30 | $112.56K 10-Q · filed 2019-11-12 | $232.96K derived: sum of 2 quarters · filed 2019-11-12 | $343.14K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $120.40K 10-Q · filed 2019-08-07 | $230.59K 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | $110.18K 10-Q · filed 2019-05-08 | |||
| 2017-09-30 | $65.81K 10-Q · filed 2018-11-07 | $116.66K derived: sum of 2 quarters · filed 2018-11-07 | $165.02K 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $50.85K 10-Q · filed 2018-08-07 | $99.21K 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $48.35K 10-Q · filed 2018-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |